NCT06938009 Dutch Registry of Pediatric Cardiac Arrest
| NCT ID | NCT06938009 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Matthijs de Hoog |
| Condition | Cardiac Arrest (CA) |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-06-14 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2023-06-14 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to understand the long-term outcomes of children in the Netherlands who experience cardiac arrest, either in or outside of the hospital. The main questions it aims to answer are: What are the survival rates and neurological outcomes in children after cardiac arrest? What types of emergency and post-resuscitation care are provided, and how do they impact long-term recovery? How do children and their families function over time after the event? Researchers will analyze data from routine medical records and follow patients through standard outpatient visits. No extra procedures will be required beyond normal care. For those who survive to hospital discharge, additional follow-up data will be collected with consent. Participants will: Be children under 18 years old who have had a cardiac arrest and were treated in one of the seven participating academic hospitals Have their routine medical care data collected anonymously Be invited (if surviving) for follow-up visits at 3, 12, and 24 months post-arrest and at specific ages (5, 8, 12, and 17 years) to assess physical and psychological recovery
Eligibility Criteria
Inclusion Criteria: * Pediatric patients under the age of 18 * Experienced in-hospital or out-of-hospital cardiac arrest in the Netherlands * Attended by emergency medical services or admitted to one of the seven participating Dutch academic pediatric hospitals * Cardiac arrest defined as absence of palpable pulse or need for chest compressions lasting ≥1 minute * Arrest managed under European Resuscitation Council guidelines (BLS/APLS) Exclusion Criteria: * Cardiac arrest occurring in neonates younger than 24 hours of age * Cardiac arrest occurring in a neonatal intensive care unit (NICU) setting
Contact & Investigator
Corinne Buysse, MD PhD
PRINCIPAL INVESTIGATOR
Erasmus Medical Center
Frequently Asked Questions
Who can join the NCT06938009 clinical trial?
This trial is open to participants of all sexes, aged 24 Hours or older, up to 18 Years, studying Cardiac Arrest (CA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06938009 currently recruiting?
Yes, NCT06938009 is actively recruiting participants. Contact the research team at gabry.dejong@erasmusmc.nl for enrollment information.
Where is the NCT06938009 trial being conducted?
This trial is being conducted at Nijmegen, Netherlands, Maastricht, Netherlands, Amsterdam, Netherlands, Groningen, Netherlands and 3 additional locations.
Who is sponsoring the NCT06938009 clinical trial?
NCT06938009 is sponsored by Matthijs de Hoog. The principal investigator is Corinne Buysse, MD PhD at Erasmus Medical Center. The trial plans to enroll 500 participants.